The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

31 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Acyclic tethers mimicking subunits of polysaccharide ligands: selectin antagonists.EBI
Institut De Recherches Cliniques De Montr£Al (Ircm)
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.EBI
Pfizer
A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists.EBI
TBA
Rational design of novel, potent small molecule pan-selectin antagonists.EBI
Revotar Biopharmaceuticals
Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.EBI
Ontogen
Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).EBI
Texas Biotechnology
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.EBI
Kanebo
Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.EBI
Kanebo
Sulfated galactocerebrosides as potential antiinflammatory agents.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.EBI
Institute Of Cancer Research
Studies on selectin blocker. 3. Investigation of the carbohydrate ligand sialyl Lewis X recognition site of P-selectin.EBI
Kanebo
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.EBI
New Drug Research Laboratory
Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids.EBI
Texas Biotechnology
Design and synthesis of a new sialyl Lewis X mimetic: how selective are the selectin receptors?EBI
Universit£
A solid-phase synthesis for beta-turn mimetics of sialyl Lewis X.EBI
Nippon Organon K.K.
Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction.EBI
Scripps Research Institute
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.EBI
Pfizer
Synthesis of fluorinated C-mannopeptides as sialyl Lewisx mimics for E- and P-selectin inhibition.EBI
Universit£
Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
 
Chemical and enzymatic synthesis of high-affinity selectin ligandsEBI
TBA
 
Design and synthesis of an α-mannosyl terpenoid as selective inhibitor of P-selectinEBI
TBA
 
Synthesis and biological activity of novel sialyl-lewisX conjugatesEBI
TBA
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.EBI
Wyeth Research
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectin.EBI
Wyeth
Sialyl Lewis(x) analogs based on a quinic acid scaffold as the fucose mimic.EBI
National Chemical Engineering Institute In Paris
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.EBI
Indian Institute Of Technology (B.H.U.)
Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist.EBI
Organon K.K.
Aryl C-glycosides: physiologically stable glycomimetics of sialyl Lewis X.EBI
Sankyo
Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.EBI
National Institute Of Pharmaceutical Education And Research (Niper)
Selectin-ligand interactions revealed by molecular dynamics simulation in solution.EBI
Kanebo
Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors.EBI
Lawrence Berkeley National Laboratories